We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Bloomin' Brands
BLMN
$924M
| $986K | ﹤0.01% |
38,448
+10,647
| +38% | +$265K |
|
677
Danaher
DHR
$143B
| $982K | ﹤0.01% |
4,394
-15,973
| -78% | -$3.63M |
|
678
Goldman Sachs
GS
$304B
| $982K | ﹤0.01% |
3,001
-1,907
| -39% | -$664K |
|
679
Aviat Networks
AVNW
$282M
| $980K | ﹤0.01% |
28,451
-549
| -2% | -$18.7K |
|
680
Chord Energy
CHRD
$7.35B
| $980K | ﹤0.01% |
7,281
-6,197
| -46% | -$842K |
|
681
Heartland Express
HTLD
$979M
| $980K | ﹤0.01% |
61,557
-31,038
| -34% | -$505K |
|
682
Cinemark Holdings
CNK
$4.37B
| $976K | ﹤0.01% |
+65,994
| New | +$801K |
|
683
HBT Financial
HBT
$1.35B
| $969K | ﹤0.01% |
49,160
-1,240
| -2% | -$25.9K |
|
684
V2X
VVX
$2.55B
| $965K | ﹤0.01% |
24,304
-1,552
| -6% | -$66.3K |
|
685
Brookfield Infrastructure
BIPC
$5.01B
| $964K | ﹤0.01% |
20,930
-30,128
| -59% | -$1.31M |
|
686
Expro Ltd
XPRO
$2.1B
| $958K | ﹤0.01% |
52,189
-9,846
| -16% | -$193K |
|
687
WaFd
WAFD
$2.81B
| $954K | ﹤0.01% |
31,661
+16,575
| +110% | +$561K |
|
688
BioLife Solutions
BLFS
$1.72B
| $954K | ﹤0.01% |
43,843
-628
| -1% | -$14.1K |
|
689
Perdoceo Education
PRDO
$1.99B
| $949K | ﹤0.01% |
70,692
-2,123
| -3% | -$29.7K |
|
690
First Financial Bankshares
FFIN
$5.04B
| $948K | ﹤0.01% |
29,731
-67,429
| -69% | -$2.34M |
|
691
InterDigital
IDCC
$8.88B
| $937K | ﹤0.01% |
12,856
-11,979
| -48% | -$834K |
|
692
Kodiak Sciences
KOD
$2.5B
| $934K | ﹤0.01% |
150,579
-2,661
| -2% | -$18.6K |
|
|
HSII
693
DELISTED
Heidrick & Struggles
HSII
| $932K | ﹤0.01% |
30,702
-10,556
| -26% | -$323K |
|
694
Privia Health
PRVA
$2.78B
| $929K | ﹤0.01% |
33,637
-2,719
| -7% | -$71.8K |
|
695
Weatherford International
WFRD
$6.6B
| $925K | ﹤0.01% |
15,586
-777
| -5% | -$45.5K |
|
696
Nurix Therapeutics
NRIX
$2.82B
| $922K | ﹤0.01% |
103,779
-2,700
| -3% | -$28.1K |
|
697
TG Therapeutics
TGTX
$7.34B
| $921K | ﹤0.01% |
61,257
-98,053
| -62% | -$1.49M |
|
698
Old Second Bancorp
OSBC
$1.31B
| $915K | ﹤0.01% |
65,075
+49,966
| +331% | +$797K |
|
699
Westamerica Bancorp
WABC
$1.39B
| $914K | ﹤0.01% |
20,628
-2,391
| -10% | -$129K |
|
700
Arlo Technologies
ARLO
$1.54B
| $913K | ﹤0.01% |
+150,593
| New | +$667K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.